KRISTIN HILL: Open Payments
NPI 1144839549 · LEBANON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,311 in 121 payments from 29 companies in 2025. Trend: 2023 $2,024 · 2024 $1,938 · 2025 $2,311
Food & beverage: $2,311
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $316 |
| AstraZeneca Pharmaceuticals LP | 12 | $235 |
| Novo Nordisk Inc | 10 | $195 |
| Corcept Therapeutics | 6 | $193 |
| Axsome Therapeutics, Inc. | 4 | $175 |
| Otsuka America Pharmaceutical, Inc. | 4 | $169 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $102 |
| Sequel Med Tech, LLC | 4 | $91 |
| Lilly USA, LLC | 5 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $77 |
Products named: Korlym, Auvelity, REXULTI, Ozempic, AIRSUPRA, VRAYLAR, BREZTRI, CAPLYTA.
Industry payments across TN — which companies pay providers there.
